SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-020097
Filing Date
2019-04-17
Accepted
2019-04-17 17:01:19
Documents
3
Period of Report
2019-04-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv518597_8k.htm 8-K 19375
2 EXHIBIT 99.1 tv518597_ex99-1.htm EX-99.1 29438
3 GRAPHIC image_001.jpg GRAPHIC 3862
  Complete submission text file 0001144204-19-020097.txt   55458
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35668 | Film No.: 19753581
SIC: 2834 Pharmaceutical Preparations